President and Chief Executive Officer, Mount Sinai Health System

__________

Kenneth L. Davis, MD, is President and CEO of the Mount Sinai Health System in New York City, one of the nation’s largest integrated health systems, which includes the Icahn School of Medicine at Mount Sinai, eight hospitals, and more than 400 ambulatory sites. He is a leader in the move away from fee-for-service medicine to population health with the aim of keeping more patients healthy and out of the hospital. As a neurobiologist, Dr. Davis conducted pioneering research that led the FDA to approve four of the first five drugs for the treatment of Alzheimer’s disease. In 2002, he was elected to the Institute of Medicine of the National Academy of Sciences. The author or co-author of more than 575 scientific articles, Dr. Davis has been recognized as one of the most highly cited researchers in the field of brain diseases. He has won numerous awards including the George H. W. Bush Lifetime of Leadership Award from Yale University. In 2014 he was named a trustee of the Aspen Institute.

Executive Director of the Mount Sinai Parenting Center
Assistant Clinical Professor of Pediatrics
Icahn School of Medicine at Mount Sinai

__________

Carrie Quinn, MD, leads the efforts behind the Mount Sinai Parenting Center at Mount Sinai Kravis Children’s Hospital, an interdisciplinary team of doctors, psychologists, researchers, and social workers which aims to transform the way pediatric health care is delivered by maximizing opportunities to impart positive parenting tools that encourage a child’s social, emotional, and cognitive growth. Her team has created a model curriculum for incorporating the promotion of positive parenting behaviors into pediatric residency training and has expanded this curriculum to pediatric residency programs throughout the country. In addition, the Parenting Center is working to transform the hospital environment with messaging and staff training to turn everyday health care moments into brain-building opportunities.

Director of the Precision Immunology Institute
Director of the Human Immune Monitoring Center
Icahn School of Medicine at Mount Sinai

__________

As the leader of the Merad Laboratory at Mount Sinai, Miriam Merad, MD, PhD, leads research to harness understanding of the immune system to develop novel therapies for cancer and inflammatory diseases. Dr. Merad’s laboratory has made pivotal discoveries in understanding the mechanisms that control the development and functional identity of tissue-resident dendritic cells and macrophages during homeostasis, and examining how these regulations are changed in cancer and inflammatory diseases. Dr. Merad also founded the Human Immune Monitoring Center at Mount Sinai to implement technology platforms to maximize information obtained from limited biological samples.

Dr. Merad has authored more than 180 papers and reviews. She receives generous funding from the National Institutes of Health (NIH), and belongs to several NIH consortia. In 2018, she received the prestigious William B. Coley Award for Distinguished Research in Tumor Immunology. She is an elected member of the American Society of Clinical Investigation.

Executive Director, Center for Thoracic Oncology
Associate Director, The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai

__________

Fred R. Hirsch, MD, PhD, has been an internationally renowned authority on lung cancer treatment and research for more than 25 years, focusing on translational research, targeted therapies, and early detection. His research has helped identify and validate prognostic markers for lung cancer outcomes and biomarkers for personalized therapies that illustrate how these therapies work and who is most likely to benefit from them.

Dr. Hirsch has received a number of awards and honors, including the IASLC Mary Matthews Award for Translational Research in Lung Cancer in 2007; the Japanese Lung Cancer Society Merit Award in 2010; the Addario Foundation Lecture Award in 2015; and the Wuan Ki Hong Lectureship Award in 2019. He has contributed to more than 400 publications in peer-reviewed journals.